Some of the bull statements: - Trial did not fail Bavi performed as expected. - bavi is simply moving to io as the market evolves very quickly. They are leaving chemo even though bavi works there. - bb (futures) - imaging (futures) - trial partners moving forward towards starting new trials - avid is growing
Reality: - trial failed, stopped for futility, company stopped all bavi/chemo. No data provided after 6 months - no trials, all early pre-clinical back to the beginning whether it's io, bb, imaging etc. - they are paying these "partners" so a pretty low bar - avid is a small manufacturer in a low-margin industry (like all manufacturing) due to its limited barrier to entry. And nothing is known of avid profitability just sales & gross profit.